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ABSTRACT
Fraser syndrome is a systemic condition characterized by cryptophthalmos, syndactyly and abnormal genitalia, which may be associated
with urinary tract, ear, nose, larynx and skeletal abnormalities. Cryptophthalmos can be an isolated finding (that has been reported as an
autosomal dominant trait) or associated with other congenital anomalies (reported as an autosomal recessive disorder). Child, female,
nine month of life, evaluated in the lacrimal setor of Federal University of São Paulo. Child of consanguineous parents. Her physical
examination showed total unilateral cryptophthalmos (left side), epiphora (right side) with mucopurulent discharge, depressed nasal
bridge, low set ears, atresia of the external auditory canal, prominent labia majora and syndactyly of the fingers and toes. Ocular
ultrasonography showed brachycephaly, absence of septu pellucidum prominence of the lateral ventricles, a major bone defect in the
skull, the presence of thinning of the mantle tissue of the brain,a reduced anterior-posterior ocular diameter, anterior segment
disorganization, absence of the lens and total retinal detachment in the left eye.
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RESUMO
A síndrome de Fraser é uma condição sistêmica caracterizada por criptoftalmo, sindactilia e anomalia da genitália, podendo se
associar com alterações dos rins, do ouvido, do nariz, da laringe e do esqueleto. O criptoftalmo pode representar um achado isolado,
representado por herança autossômica dominante, associado a outras anomalias congênitas, relatado como herança autossômica
recessiva. Criança do sexo feminino, 9 meses, avaliada no ambulatório de vias lacrimais da Universidade Federal de São Paulo. Filha
de pais consanguíneos. Ao exame, foram observados criptoftalmo total à esquerda, epífora em olho direito associada à secreção
mucopurulenta, nariz em sela, implantação baixa das orelhas, malformação de conduto auditivo, aumento de grandes lábios e sindactilia
de mãos e pés. A tomografia de crânio evidenciou braquicefalia ausência de septo pelúcido, proeminência dos ventrículos laterais,
importante falha óssea na calota craniana, presença de afilamento do manto tecidual cerebral, fossa posterior pequena, desorgani-
zação do segmento anterior, afacia e descolamento total da retina.
Descritores: Obstrução dos ductos lacrimais/congênito; Dacriocistite; Síndrome; Relatos de casos
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INTRODUCTION
Fraser syndrome(1) was first described by the Canadiangeneticist Fraser in 1962 and occurs with a minimalestimated frequency of 0.43 per 100,000 live births. It is a
systemic condition characterised by the following defects:(2-4)
a) Face: cryptophthalmos (93%), usually bilateral and
associated with eye defects; hair growth laterally to the forehead
until the side of the eyebrows (34%); depression of the underlying
frontal bone; hypoplastic notched nostrils; broad nose with a
depressed nasal bridge; ear anomalies (44%), such as atresia of
the external auditory canal and cupped ears.
b)  Performance: mental deficiency in 50% of survivors.
c)  Limbs: partial skin syndactyly (57%).
d) Genitalia: incomplete development (49%); male:
hypospadias, cryptorchidism; female: bicornuate uterus, vaginal
atresia, clitoromegaly.
e) Other: laryngeal atresia or stenosis (21%); renal
agenesis or hypoplasia (37%); microcephaly; hydrocephalus;
encephalocele; myelomeningocele; cleft lip; cleft palate (4%);
short tongue frenulum (96%); absence of eyelashes and eyebrows;
microphthalmia; anophthalmia; corneal opacity; anal atresia; small
intestine malformations; heart defects; missing phalanges;
hypoplastic or missing thumb.
Diagnosis should be based on the presence of two major
and one minor criteria or one major and four minor criteria. The
diagnostic criteria for Fraser syndrome are:
a) Major: cryptophthalmos; symblepharon; syndactyly;
genital abnormalities.
b) Minor: nose, ear, and larynx malformations; umbilical
hernia; kidney abnormalities; bone abnormalities; cleft tongue
or other oral clefts; mental retardation.
About 20% of affected individuals die before one year of
age, usually due to kidney or laryngeal defects.
Abnormal eyelid development is generally associated with
ocular abnormalities.(5)
The disease has an autosomal recessive inheritance. The
aetiology of cryptophthalmos is variable.(6)
Cryptophthalmos is the most frequent finding(5,6): it is present
in 95% of cases, being bilateral in 57% and unilateral in 25%.
Cryptophthalmos is the congenital fusion of eyelids due to critical
defects in eye development, leading to a poor visual prognosis.
The aim of surgery(7,8) is to protect and optimise the eye’s
visual potential. When there is no visual potential, the secondary
goal is eyelid reconstruction. Rehabilitation is challenging, and
the visual prognosis should be carefully discussed with parents.
The condition may be associated with hypertelorism,
microphthalmia, supernumerary eyebrows,(5,6) and an abnormal
or absent conjunctival fornix. The cornea may be covered by a
tissue similar to the sclera and present staphyloma. Other findings
have been described such as an absent lens and iris; an anterior
chamber filled with vitreous humour; microphakia with iris, ciliary
body and choroidal atrophy; and retinal disorganisation.
In most cases the anterior segment is more severely
affected.
The incidence of congenital obstruction of the nasolacrimal duct
is 6%,(9) but it is higher in children with craniofacial anomalies.(10)
Congenital nasolacrimal obstruction may be due to
incomplete development of the bony nasolacrimal canal,
craniofacial anomalies, and most often due to the persistence of
a mucous membrane at the level of Hasner’s valve. About 82%(11)
of cases resolve with conservative treatment in the first year of
life. After this age, lacrimal probing is indicated.
CASE REPORT
White female child born and raised in São Paulo and seen
at UNIFESP’s Lacrimal Pathways Unit since she was 9 months
old. The patient had Fraser syndrome with tearing in the right
eye since birth (Figure 1). Ophthalmic examination showed:
mucopurulent discharge in the right eye, no hyperaemia in the
bulbar conjunctiva, Milder test +++, negative oropharynx
fluorescein appearance test, and cryptophthalmos in the left eye.
Figure 1: Part of the face of child with Fraser syndrome.
Figure 2:  CT slice obtained with a thickness of 3 and 10 mm.
Multislice computed tomography of the head showed:
brachycephaly, absent septum pellucidum, prominent lateral
ventricles, major skull bone defect, thinning of the brain mantle,
small posterior fossa (Figure 2).
Conservative management was adopted, and the epiphora
in the right eye resolved after 4 months.
DISCUSSION
Craniofacial anomalies are a diverse and complex set of
conditions. Craniofacial anomalies include isolated and multiple
anomalies of genetic or non-genetic origin and are characterised
by changes in the structure of the skull and/or face.(12,13)
A considerable proportion of patients with craniofacial
anomalies have a normal life expectancy, as only a minority of
presentations are lethal.(12) In Fraser syndrome, 25% of affected
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